Financhill
Back

Cytokinetics Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
42

CYTK
Cytokinetics

Last Price:
51.37
Seasonality Move:
10.01%
Sell
45

BMRN
Biomarin Pharmaceutical

Last Price:
66.67
Seasonality Move:
14.81%
Sell
42
Cytokinetics (CYTK) is a Sell

Is Cytokinetics a Buy, Sell or Hold?

  • The current Cytokinetics [CYTK] share price is $51.51. The Score for CYTK is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • CYTK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Biomarin Pharmaceutical (BMRN) is a Sell

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $69.92. The Score for BMRN is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • BMRN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CYTK Stock Price Chart

What is Cytokinetics's stock price today?

  • The Cytokinetics share price today is $51.51
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing slight selling pressure.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $69.92
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.

CYTK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.65 Sell
Relative Strength Index (14 RSI): 40.31 Sell
Chaikin Money Flow: -241160 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.28 - 55.12) Sell
Bollinger Bands (100): (52.99 - 56.93) Sell

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.45 Sell
Relative Strength Index (14 RSI): 39.76 Sell
Chaikin Money Flow: 90332 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (69.27 - 70.47) Buy
Bollinger Bands (100): (73.08 - 88.64) Sell

CYTK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.03 Sell
20-day SMA: 53.96 Sell
50-day SMA: 54.65 Sell
200-day SMA: 62.09 Sell
8-day EMA: 52.73 Sell
20-day EMA: 53.56 Sell
50-day EMA: 54.42 Sell
200-day EMA: 55.79 Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 70.13 Sell
20-day SMA: 69.85 Buy
50-day SMA: 77.12 Sell
200-day SMA: 83.38 Sell
8-day EMA: 70.07 Sell
20-day EMA: 70.78 Sell
50-day EMA: 74.81 Sell
200-day EMA: 82.2 Sell

Cytokinetics Earnings Growth & CYTK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.28 per share, and an increase next year of $0.22 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.18 per share, and an increase next year of $0.95 per share.

Cytokinetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):